Volume 41, Supplement 2, C174-C176, DOI: 10.1007/BF01987627

Amelioration of established collagen-induced arthritis (CIA) with anti-IL-1

L. A. B. Joosten, M. M. A. Helsen, F. A. J. van de Loo and W. B. van den Berg

View Related Documents

Abstract

Inflammatory cytokines have been implicated in the pathogenesis of rheumatoid arthritis (RA). To investigate the role of interleukin-1 (IL-1) and tumor necrosis factor agr (TNFagr) in arthritic processes we studied the effect of neutralizing antibodies against murine IL-1 and TNFagr in murine collagen-induced arthritis (CIA). Combined i.p. injection of anti-IL-1agr and anti-IL-1beta (anti-IL-1agr,beta), given before onset of the disease, completely prevented CIA. In contrast, treatment with anti-TNFagr at this time point only delayed the onset of arthritis. Remarkably, a single injection of anti-IL-1agr,beta was also highly effective in suppressing established arthritis, reducing both inflammation and cartilage destruction. Suppression was most pronounced with the combination of anti-IL-1agr and beta, but anti-IL-1beta alone also gave significant relief. Specific antibodies against TNFagr had no effect on established CIA. Of interest, anti-IL-1agr,beta treatment started after onset of CIA completely normalized chondrocyte synthetic function, which was highly suppressed in the non-treated group. It is concluded that IL-1 and TNFagr are important cytokines during the onset of CIA and that IL-1 is the key mediator of inflammation and cartilage damage in established CIA.

Fulltext Preview

Image of the first page of the fulltext document